Current status of organ transplantation in Japan

American Journal of Transplantation

Volumn 12, Issue 3, 2012, Pages 523-530

  Egawa, H ^a   Tanabe, K ^a   Fukushima, N ^b   Date, H ^c   Sugitani, A ^d   Haga, H ^e  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d FUJITA HEALTH UNIVERSITY HOSPITAL   (Japan)

^e KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

blood type; Brain death; incompatible transplantation; living donor liver transplantation

Indexed keywords

BLOOD GROUP INCOMPATIBILITY; BLOOD GROUP TYPING; BRAIN DEATH; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JAPAN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LIVING DONOR; LUNG TRANSPLANTATION; MORBIDITY; ORGAN DONOR; ORGAN TRANSPLANTATION; PANCREAS TRANSPLANTATION; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW;

HUMANS; JAPAN; ORGAN TRANSPLANTATION; TISSUE DONORS;

EID: 84857647011     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03822.x     Document Type: Review

References (30)

1. Fukushima N, Ono M, Nakatani T, Minami M, Konaka S, Ashikari J,. Strategies for maximizing heart and lung transplantation opportunities in Japan. Transplant Proc 2009; 41: 273-276.
2. Shiraishi T, Okada Y, Sekine Y, et al,. Registry of the Japanese Society of Lung and Heart-Lung Transplantation: The official Japanese lung transplantation report 2008. Gen Thorac Cardiovasc Surg 2009; 57: 395-401.
3. Date H., Lung transplantation in Japan. Surg Today 2004; 34: 565-568. (Pubitemid 38887986)
4. Miyoshi K, Oto T, Okazaki M, et al,. Extracorporeal membrane oxygenation bridging to living-donor lobar lung transplantation. Ann Thorac Surg 2009; 88: 56-57.
5. Date H, Aoe M, Sano Y, et al,. Improved survival after living-donor lobar lung transplantation. J Thorac Cardiovasc Surg 2004; 128: 933-940. (Pubitemid 39575300)
6. Mizuta K, Yasuda Y, Egami S, et al,. Living donor liver transplantation for neonates using segment 2 monosegment graft. Am J Transplant 2010; 10: 2547-2552.
7. Akabayashi A, Slingsby BT, Fujita M,. The first donor death after living-related liver transplantation in Japan. Transplantation 2004; 77: 634. (Pubitemid 38282830)
8. Takayama T, Makuuchi M, Kubota K, Sano K, Harihara Y, Kawarasaki H,. Living-related transplantation of left liver plus caudate lobe. J Am Coll Surg 2000; 190: 635-638. (Pubitemid 30230712)
9. Sugawara Y, Makuuchi M, Imamura H, Kaneko J, Kokudo N,. Outflow reconstruction in extended right liver grafts from living donors. Liver Transplant 2003; 9: 306-309. (Pubitemid 36322334)
10. Ogura Y, Hori T, El Moghazy WM, et al,. Portal pressure <15 mm Hg is a key for successful adult living donor liver transplantation utilizing smaller grafts than before. Liver Transplant 2010; 16: 718-728.
11. Ito T, Kiuchi T, Yamamoto H, et al,. Changes in portal venous pressure in the early phase after living-donor liver transplantation: Pathogenesis and clinical implications. Transplantation 2003; 75: 1313-1317. (Pubitemid 36513040)
12. Hashikura Y, Ichida T, Umeshita K, et al,. Donor complications associated with living donor liver transplantation in Japan. Transplantation 2009; 15: 110-114.
13. Kenmochi T, Asano T, Maruyama M, et al,. Living donor pancreas transplantation in Japan. J Hepatobiliary Pancreat Surg. 2010; 17: 101-107
14. Annual Progress Report from the Japanese Renal Transplant Registry, 2010. Part III: Results from 2009 Recipient Follow-up Survey. The Japanese Society for Clinical Renal Transplantation. Japan Soc Transplant Ishoku (Japan J Transplant) 2010; 45: 608-620.
15. Tojimbara T, Fuchinoue S, Iwadoh K, et al,. Improved outcomes of renal transplantation from cardiac death donors: A 30-year single center experience. Am J Transplant 2007; 7: 609-617. (Pubitemid 46376447)
16. Egawa H, Teramukai S, Haga H, Tanabe M, Fukushima M, Shimazu M,. Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology 2008; 47: 143-152. (Pubitemid 351171051)
17. Egawa H, Ohmori K, Haga H, et al,. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation. Liver Transplant 2007; 13: 579-588. (Pubitemid 46605862)
18. Ikegami T, Taketomi A, Yoshizumi H, et al,. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: A new protocol in ABO incompatible living donor liver transplantation. Transplantation 2009; 88: 303-307.
19. Irei T, Ohdan H, Zhou W, et al,. The persistent elimination of B cells responding to blood group A carbohydrates by synthetic group A carbohydrates and B-1 cell differentiation blockade: Novel concept in preventing antibody-mediated rejection in ABO-incompatible transplantation. Blood 2007; 110: 4567-4575. (Pubitemid 351377825)
20. Haga H, Egawa H, Shirase T, et al,. Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation. Liver Transpl 2004; 10: 16-27. (Pubitemid 38885888)
21. Tanabe K, Takahashi K, Sonda K, et al,. Long-term results of ABO-incompatible living kidney transplantation. A single-center experience. Transplantation 1998; 65: 224-228. (Pubitemid 28101328)
22. Tanabe K, Ishida H, Kouhei N, Shimizu T, Shirakawa H, Omoto K,. Significant treatment in ABO-incompatible living kidney transplantation. (presented at ATC in 2011, abstract # 265). Am J Transplant 2011; S2: 111.
23. Ishida H, Hirai T, Kohei N, Yamaguchi Y, Tanabe K,. Significance of qualitative and quantitative evaluations of anti-HLA antibodies in kidney transplantation. Transpl Int 2011; 24: 150-157.
24. Sugawara Y, Tamura S, Kaneko J, Togashi J, Makuuchi M, Kokudo N,. Positive lymphocytotoxic crossmatch does not adversely affect survival in living donor liver transplantation. Dig Surg 2010; 26: 482-486.
25. Ashihara E, Tsuji H, Sakashita H, et al,. Antidonor antibody in patients receiving ABO-identical and HLA-mismatched living donor liver transplants: effect on survival. Transplantation 2007; 83: 506-509. (Pubitemid 46667855)
26. Hori T, Egawa H, Takada Y, et al,. Fatal impact of lymphocyte cross-matching upon humoral rejection after adult living related liver. Transpl Int 2010; 23: 338-340.
27. Yoshitomi M, Koshiba T, Haga H, et al,. Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation. Transplantation 2009; 87: 606-614.
28. Onoe T, Ohdan H, Tokita D, et al,. Liver sinusoidal endothelial cells toleriz T cells across MHC barriers in mice. J Immunol 2005; 175: 139-146. (Pubitemid 40884310)
29. Tahara H, Tanaka Y, Ishiyama K, et al,. Successful hepatitis B vaccination in liver transplant recipients with donor-specific hyporesponsiveness. Transpl Int 2009; 22: 805-813.
30. Egawa H, Ozawa K, Takada Y, et al,. Coupled regulation of interleukin-12 receptor beta-1 of CD8+ central memory and CCR7-negative memory T cells in an early alloimmunity in liver transplant recipients. Clin Exp Immunol 2010; 160: 420-430.